Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Dermatology | Endocrinology | Family Medicine | Nursing | Pediatrics | Journal

Back to Journal Articles

Obesity More Common Among Children With Psoriasis

Last Updated: November 19, 2012.

 

Excess adiposity and waist circumference more common with severe disease; particularly in U.S.

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Children with psoriasis are more likely to be obese, particularly if they have severe disease or live in the United States, according to a study published online Nov. 19 in the Archives of Dermatology.

MONDAY, Nov. 19 (HealthDay News) -- Children with psoriasis are more likely to be obese, particularly if they have severe disease or live in the United States, according to a study published online Nov. 19 in the Archives of Dermatology.

Amy S. Paller, M.D., from Northwestern University in Chicago, and colleagues assessed overweight and obesity in 614 children (5 to 17 years old) from nine countries across the Americas, Europe, and Asia, where 409 had psoriasis and 205 did not have skin or inflammatory disease.

The researchers found that 37.9 percent of children with psoriasis and 20.5 percent of controls had excess adiposity (body mass index ≥85th percentile). Children with psoriasis were more likely than controls to be obese (odds ratio [OR], 4.29). Obesity was more common in severe psoriasis than mild disease (OR, 4.92 versus 3.60), especially in the United States (OR, 7.60 versus 4.72). The proportion of children with excess waist circumference was increased among those with psoriasis, increased with psoriasis severity, and was highest in the United States. The waist-to-height ratio was significantly higher in children with psoriasis but was not associated with psoriasis severity.

"Globally, children with psoriasis have excess adiposity and increased central adiposity regardless of psoriasis severity," Paller and colleagues conclude. "The increased metabolic risks associated with excess and central adiposity warrant early monitoring and lifestyle modification."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Tractable Preclinical Model Proposed for Ulcerative Colitis Next: Repeat Testing Common Among Medicare Beneficiaries

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.